| abstract |
The present invention relates to the use of a renin-angiotensin (RAS) inhibitor or a pharmaceutically acceptable derivative thereof, in particular ramipril or ramiprilat, in the manufacture of a medicament for the prevention of stroke, diabetes. The present invention also relates to a method for the prevention and / or treatment of stroke, diabetes, comprising administering a therapeutically effective amount of a RAS inhibitor or a pharmaceutically acceptable derivative thereof, in particular ramipril or ramiprilat, to a patient in need of such prevention and / or treatment. |